Institute of Cancer Research launch “Darwinian” cancer drug programme

The Institute of Cancer Research has launched the world’s first ‘Darwinian’ cancer drug programme, aiming to deliver step change in cancer treatment. The programme is specially designed to tackle cancer’s lethal ability to evolve resistance to treatment and is to be launched in a £75 million state-of-the-art global centre of expertise in anti-evolution therapies in

Continue Reading